Use of Parallel Transmit 7T MRI Changes Management for Epilepsy Surgery
By Elana Gotkine HealthDay Reporter
THURSDAY, March 27, 2025 -- Parallel transmit (pTx) 7 Tesla (T) magnetic resonance imaging (MRI) changes management in more than half of adult candidates for epilepsy surgery, according to a study published online March 20 in Epilepsia.
Krzysztof Klodowski, Ph.D., from the University of Cambridge in the United Kingdom, and colleagues compared pTx and circularly polarized (CP) 7T MRI in adult candidates for epilepsy surgery who had negative or equivocal 3T MRI. Outcomes were reported for the first 31 patients.
The researchers found that 7T revealed previously unseen structural lesions, confirmed 3T-equivocal lesions, and disproved equivocal lesions in nine, four, and four patients, respectively (29, 13, and 13 percent). In 57 percent of cases, lesions were better visualized on pTx than CP and were never better visualized on CP. In 18 cases (58 percent), clinical management was altered by 7T: Nine were offered surgical resection and one laser interstitial thermal therapy; three were removed from the surgical pathway due to bilateral or extensive lesions; and five were offered stereo-electroencephalography with better targeting. Significantly better overall quality of pTx fluid-attenuated inversion recovery images was confirmed in blinded comparison, while magnetization-prepared 2 rapid acquisition gradient echo images were noninferior and had improved temporal lobe coverage and less signal dropout.
"The introduction of pTx-7T MRI to a real-world epilepsy surgery pathway changed clinical management for more than half of the patients scanned, making it highly likely that it will be cost-effective in patients with normal 3T MRI," the authors write.
Two authors disclosed ties to Siemens and Siemens Healthcare.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted March 2025
Read this next
Tumor-Related Epilepsy Not Strong Prognostic Factor in Diffuse Glioma
WEDNESDAY, May 21, 2025 -- For patients with diffuse gliomas, tumor-related epilepsy (TRE) is not a strong prognostic factor, according to a study published in the May issue of...
Persistent, New Mucus Plugs Associated With Faster Decline in FEV1 in COPD
WEDNESDAY, May 21, 2025 -- For patients with chronic obstructive pulmonary disease (COPD), persistent and newly formed mucus plugs are associated with a faster decrease in forced...
Combinations of Chronic, Physical Illnesses Up the Risk of Subsequent Depression
WEDNESDAY, May 21, 2025 -- Certain groups of physical multimorbidity may be associated with a higher risk of subsequent depression, according to a study published online May 13...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.